Spatial Genomics and Transcriptomics Market Future Trends & Growth

-

The global spatial genomics and transcriptomics market is expected to grow from USD 355 million in 2022 to USD 800 million by 2027, exhibiting a robust CAGR of 17.6%. This growth is primarily driven by the increasing adoption of spatial genomics and transcriptomics techniques in drug discovery and development. Additionally, the rise in research and development investments and public-private funding, along with the introduction of technologically advanced instruments, are propelling market expansion.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=170900551

Understanding Market Dynamics

Spatial Transcriptomics Techniques Lead the Market

The spatial genomics and transcriptomics market is segmented into spatial transcriptomics techniques and spatial genomics analysis techniques. In 2021, spatial transcriptomics techniques accounted for the largest share of the global market. This growth is attributed to their high adoption in drug discovery and development, the introduction of novel products, and increasing research and development investments.

Consumables Segment Drives spatial genomics & transcriptomics market Growth

Among product segments, consumables emerged as the largest-growing segment of the spatial genomics and transcriptomics market in 2021. The increasing applications of spatial genomics and transcriptomics in drug discovery and development, biomarker identification, and the growing use of consumables are key factors driving market growth.

North America Leads the spatial genomics & transcriptomics market

North America holds the largest share in the global spatial genomics and transcriptomics market, followed by Europe. The region's dominant position is due to the rising focus on drug discovery and development, driven by the growing incidence of chronic and genetic diseases, as well as the rapidly growing aging population. These factors support the widespread adoption of spatial genomics and transcriptomics technologies in the region.

Key Market Players

The spatial genomics and transcriptomics market is characterized by its consolidated nature, with several prominent players leading the industry. Key players include NanoString Technologies, Inc. (US), 10X Genomics (US), Illumina (US), Bio-Rad Laboratories (US), Bio-Techne Corporation (US), Standard BioTools Inc. (US), Genomic Vision SA (France), Akoya Biosciences, Inc. (US), and Danaher Corporation (US), among others.

Request Free Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=170900551

Conclusion

The spatial genomics and transcriptomics market is witnessing significant growth, driven by advancements in technology and increased research and development activities. As the demand for precise and efficient diagnostic tools rises, the market is expected to expand further. With key players focusing on innovation and the development of advanced instruments, the future of spatial genomics and transcriptomics looks promising.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

Comments

Post a Comment

Popular posts from this blog

Future of Remote Patient Monitoring Industry: Impact of Remote Patient Monitoring on Healthcare

-
Remote patient monitoring is a type of telemedicine technology that enables healthcare providers to monitor their patients’ health remotely. This technology utilizes remote devices that are placed in the patient’s home or worn by the patient to collect medical data such as vital signs and other medical information.  This medical data is then transmitted to the doctor or healthcare provider to help them make better decisions regarding the patient’s care. RPM can be used to monitor a variety of conditions including chronic diseases, mental health issues, and post-operative care. It can also be used to support elderly individuals and those with disabilities. RPM has the potential to improve patient outcomes and reduce healthcare costs by enabling healthcare providers to monitor their patients’ health more effectively. Benefits of Remote Patient Monitoring 1. Increased Patient Engagement: Remote patient monitoring systems provide patients with a convenient way to stay engaged in their ow
Read more

Sinus Dilation Devices Market Size And Share Report, 2027

-
The sinus dilation devices market is on track for significant growth in the coming years, projected to reach USD 3.8 billion by 2027, up from USD 2.8 billion in 2022. This represents a compound annual growth rate (CAGR) of 6.6% during the forecast period. The market's expansion is largely driven by the increasing availability of reimbursements and rising cases of chronic sinusitis. However, the market faces challenges due to the availability of non-surgical treatments for chronic sinusitis and a shortage of skilled ENT surgeons. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=64349810 Key Market Drivers Increasing Availability of Reimbursements: The growing availability of reimbursements for sinus dilation procedures is making them more accessible to patients, thereby driving demand for sinus dilation devices. Rising Incidence of Chronic Sinusitis: The prevalence of chronic sinusitis is on the rise globally, leading to an increase in d
Read more

Stable Isotope Labeled Compounds Market Growth: Trends and Opportunities

-
The global stable isotope labeled compounds market size is projected to reach USD 312 million by 2024 from USD 269 million in 2019, at a CAGR of 3.0% between 2019 and 2024. The growth of this market is driven majorly by the increase in research activities in the pharmaceutical and biotechnology sector, the rising prevalence of cancer, and rising proteomics research. However, the high cost of stable isotope-labeled compounds is expected to restrain the growth of this market during the forecast period. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=53034199 The H-2 labeled compounds segment accounted for the largest share of the stable isotope labeled compounds market. Based on type, the stable isotope labeled compounds industry is segmented into C-13, N-15, O-18, H-2 (deuterium), and other isotopes. The H-2 labeled compounds segment accounted for the largest share of the stable isotope-labeled compounds market in 2019. The large share of this
Read more